SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-069883
Filing Date
2009-12-10
Accepted
2009-12-10 16:41:40
Documents
3
Period of Report
2009-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w76548e8vk.htm 8-K 23956
2 EXHIBIT 10.1 w76548exv10w1.htm EX-10.1 87499
3 GRAPHIC w76548w7654800.gif GRAPHIC 4879
  Complete submission text file 0000950123-09-069883.txt   119958
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 091234123
SIC: 2834 Pharmaceutical Preparations